Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00682734 · ClinicalTrials.gov registry record · Phase 3
Metoclopramide for Migraine: A Dose Finding Study
A Phase 3 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 349
- Enrollment target
NCT00682734 is a Phase 3 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 349 participants.
The verdict
NCT00682734, a Phase 3 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 349 participants
- Enrollment target
Study Summary
Metoclopramide is an effective intravenous treatment for acute migraine attacks, but we do not know the best dose to administer. This study compares three different doses of metoclorpamide.
Interventions
- DRUG metoclopramide
- DRUG Diphenhydramine 25mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00682734
The ClinicalTrials.gov registry entry for NCT00682734 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 349 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which metoclopramide is the first listed.
NCT00682734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00682734 about?
NCT00682734 is a clinical study titled "Metoclopramide for Migraine: A Dose Finding Study". Metoclopramide is an effective intravenous treatment for acute migraine attacks, but we do not know the best dose to administer. This study compares three different doses of metoclorpamide.
What is the current status of trial NCT00682734?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 349 participants. The study started on 2008-04. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00682734?
The interventions under investigation include: metoclopramide (DRUG), Diphenhydramine 25mg (DRUG).
Who is sponsoring clinical trial NCT00682734?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.